Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Group
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.0398	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.0871	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.1707	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2134	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2199	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2338	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2432	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2496	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2508	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2544	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2569	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2689	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2695	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2851	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.2884	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.3290	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4039	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4150	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4218	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4339	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4553	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4635	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4777	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4837	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4985	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.4991	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.5270	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.5347	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.5611	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.5917	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.5930	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.5964	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.6051	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.6377	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.6549	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.6673	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7081	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7088	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7186	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7202	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7220	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7400	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7440	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7500	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7622	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7707	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7855	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.7984	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8298	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8303	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8313	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8496	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8504	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8596	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.8608	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9066	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9075	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9318	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9446	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9720	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9721	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9741	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9802	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9829	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	0.9985	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0000	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0164	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0414	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0628	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0665	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0730	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0760	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.0995	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1116	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1148	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1378	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1394	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1466	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1515	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1679	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1749	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1851	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1862	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1933	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.1960	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.2046	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.2057	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.2318	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.2691	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3095	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3182	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3235	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3406	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3497	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3566	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3605	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.3799	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.4511	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.5073	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.5191	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6246	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6285	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6528	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6673	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6704	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6808	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.6992	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.7029	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.7030	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.7031	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.7192	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.8168	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.8718	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.8769	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.8927	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.9034	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.9071	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	1.9549	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.0318	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.0579	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.1572	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.3744	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.5477	Peak area	Lean
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.6725	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.7682	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	2.9319	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	3.0032	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	3.0102	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	3.0644	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	3.8683	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	palmitoleate (16:1n7)	4.6787	Peak area	Obese non neuropathy